🇺🇸 Bupropion-Naltrexone in United States

27 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Generalised Tonic-Clonic Seizure — 6 reports (22.22%)
  2. Drug Interaction — 5 reports (18.52%)
  3. Abnormal Weight Gain — 3 reports (11.11%)
  4. Bundle Branch Block Right — 3 reports (11.11%)
  5. Metabolic Disorder — 3 reports (11.11%)
  6. Weight Increased — 3 reports (11.11%)
  7. Condition Aggravated — 1 report (3.7%)
  8. Dizziness — 1 report (3.7%)
  9. Dyskinesia — 1 report (3.7%)
  10. Dysmenorrhoea — 1 report (3.7%)

Source database →

Bupropion-Naltrexone in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Bupropion-Naltrexone approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Bupropion-Naltrexone in United States?

WW International Inc is the originator. The local marketing authorisation holder may differ — check the official source linked above.